Smart oxygen machine aims to get COPD patients out of hospital faster

NCT ID NCT03835741

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a device called FreeO2 that automatically adjusts oxygen levels for people hospitalized with a COPD flare-up. The goal was to see if it could shorten hospital stays compared to manual oxygen adjustment by staff. Only 17 people took part, and the study was stopped early, so we don't have clear answers yet.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
FreeO2 device (automated oxygen adjustment)
What this could lead to
If it works, this could reduce hospital stays for COPD flare-ups by automatically adjusting oxygen levels.
What could go wrong
The trial was terminated early and enrolled only 17 people, so results are very limited. Automated oxygen may not work better than standard manual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD EXACERBATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut Universitaire de Cardiologie et de Pneumologie de Québec

    Québec, Quebec, G1V4G5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.